Why One Drug Company Held Back a Better Drug

Why One Drug Company Held Back a Better Drug

Up next

The Case of Kristie Metcalfe

Warning: This episode contains strong language. The Civil Rights Division of the Justice Department — founded to focus on fighting race-based discrimination — has drastically changed the kinds of cases it pursues, dropping or setting aside many already in progress. Sarah Koenig f ...  Show more

The U.S. Errors That Led to the Airstrike on an Elementary School

A continuing military investigation has determined that the United States is responsible for a strike that hit an elementary school in Iran, according to U.S. officials and others familiar with the preliminary findings. Iranian officials have said the death toll was at least 175 ...  Show more

Recommended Episodes

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Business

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Sick Money (Pt 1): Exposing the drug companies' price gouging tactics
The Story

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

  Show more

Long Reads: Big Pharma's Toxic Record w/ Nick Dearden
Jacobin Radio

From the HIV/AIDS crisis, to the opioid epidemic, to the COVID-19 pandemic, pharmaceutical corporations have been accused of profiteering at the expense of countless lives. Nick Dearden, director of Global Justice Now and the author of a new book called <a href="https://www.ve ...

  Show more

Why are drug prices so high? Investigating the outdated US patent system | Priti Krishtel
TED Talks Daily

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more